Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
In a past PR, SS, they specified the nation, region and hospital name these "Volunteer Trials" were to occur. When nothing came to pass with a lame customs agreement issue to allow the IPV-1 into the country in a Notice from ENZC, it was thought to be a very temporary issue.
You know the rest, no one's heard anything back on that, Chandra runs from that question, and you can bet another lame excuse, forever-delay is about to be dropped on us soon.
The complete lack of transparency and integrity with their shareholders cites the biggest risk of all. Sure, many companies might not comment on it, but ENZC has too many of these excuse-ridden operations now.
Now doc, SSPalmo is one of the good ones here. The detail-devoid bashers are the morons, as are some of the blind pumpers. I get what you're saying, and its exactly what I'm hoping for.
I've done well on the Pinks since about 2002, but also seen signs of scams and elaborate common shareholding theft often enough too. ENZC shows signs of real success, and signs of elaborate bait-n-switch scamming as well. Which is why I say CC is not that smart. If he has success, his amateur approach to a funding partner, so far, gives this ticker as much genuine stink as there is praiseworthy information with them.
His missed milestones, by a huge margin-missed, and his broken promises are very concerning to me. A lot of the top and smartest investors would be gone from here already, Not all, but a respectable many.
I'm giving ENZC time to do something significant, but probably not much more time past this Fall.
GLTY!
I understand CK, but I've sent 5, nice, polite ones over 2 years now, not ever one reply or posted response to any. I've seen many others on this board, X, and the old FB groups all tell me they never get a reply back from Charles either.
I got through to Chandra once, and he closed off communications ever since after I got him scheduled for an interview on The Blaze.com He canceled last second, and has never been heard from again, except for fluff-post exceptions on X.
I would say, "good luck with that."
GLTA
Getting an SEC warning or just an alert that there are complaints coming in about ENZC, does nothing to jeopardize our stock. It would be self-defeating not to join such an effort, as you just know someone is already complaining to them now about ENZC. The more the SEC gets, the greater the odds they will reach out and notify ownership.
It's only a reminder to fly right, avoid potentially damaging practices on ENZC's part. How do you get anyone, much less the SEC to re-regulate OTC:Pinks ?? It's a never-will-happen-deal. I don't think Charles & Co. listen much to common shareholders at all, except for appearances only. The SEC is not bound at all to stop short selling of a stock until brokerages report it, and some won't. Then the brokerages begin suspending short-seller's account privileges, not the SEC. SEC won't become involved in PINK enforcement, unless someone has a lawsuit make it past a small claims court on up to a district level. Most county courts don't have jurisdiction either.
ENZC has had a lot of years, first under Joe, now under Charles, and there's just too many missed milestone/timeline events, broken promises and attempts to screw around with share values. All of which Charles promised to not let happen. There's also been a ridiculous court history following ownership and patents like flies on bbq.
I'd get some polite, detailed and numerous complaint letters into the SEC, and may send mine soon. If that caused anything to tank, ENZC was a scam from the start. I still don't think that is the case, but complaint letters to the SEC risk nothing, and carry at least a little weight, whereas ownership at ENZC probably won't even open received shareholder letters.
GLTA
It can't hurt. There should also be a lot of specific inquiry letters to the SEC, regarding the misrepresentations of timelines, share promises, SEC uplisting for NASDAQ, or even to OTC:QB. Any broken promise or misrepresentation by ENZC should be addressed.
The SEC never issues a warning or prompts a company to do better on disclosures unless they get a lot of complaints where a pink stock is involved. If they get no rash of complaints, they ignore Pink Stocks altogether as unregulated.
But they do have the option of taking action, even where a pink stock is concerned, which the first step would be notifying ENZC that they are receiving the complaints.
Not sure what would make Charles speak out faster and get the message he's on notice to fly right, a bunch of shareholder letters, or the first hint of a warning by the SEC.
Think I'll go check this out, thanks. If ENZC turns out to be something good, fine, but such a video may help me warn some other friends of mine about some other scams I know of in the Pinks that I got out of years ago, and they're winding up the same show again now years later.
Agreed, hearing something of substance is kinda' crucial right now, with the stock at an all-time low for me right now.
GLTY
Hey Bonnie, just FYI, I was not referring to the original SAGA deal terms, where we'd get shares in SAGA based upon a fairly decent trade-in proportion on pps, and retain shares in ENZC. I was referring to the announcement, short-lived as it was, AFTER, allegedly, the deal was signed, closed and just awaiting the funding date. I was referring to the announcement where the shares would be less than half what was first promised after the dividend would go out. The shares would not be converted to the amount of shares as promised, but a little less than half of that. with a disclaimer that it could get devalued further. All promises made before, were suddenly subject to the trash heap at Catropia's and Koskinen's discretion.
That was downright criminal. Either he had a deal or he did not. Thats pure OTC:Pink badlands, and not ever what was even alluded to. Now, if he gets another SPAC, I'd expect a good deal promise again, only to have a not-so-disguised big reverse split hitting us out of nowhere.
Then the lawsuit came in, that may have saved us all, if a hail-mary in funding or patent approval(s) come in. You either have a deal or you never did. That type of last-second about face is nothing Catropia 'had to do'. He should have had published, inexpensive private trials by now, with results dragging in BP or other funding parties, excited to help get final approvals.
As much as I've been a big fan of ENZC, it smells really bad right now. Too many broken promises, disregarded delays and after a couple of years of noted progress, its sounding like it did before as a rerun of failure before the management got shook up from Joe's unsuccessful run.
GLTA
I think something else is going on, or they'd have been in bankruptcy already, by my humble estimation. I wish someone at Texas A&M would return a call from the PreTrial Clinical Sciences Center,, just to tell us if ENZC still maintains a lab there. I can't get there myself until 4/25.
GLTY
Boeing may really have been the wrong choice in MFG's mechanics as of late.
Good idea.
No argument there. There was a published peer review that the summary and dates, authors and authencitiy credentials were published on the Texas A&M website. I certainly was not the only one here who read it.
My worry was, no Agreement proof about Samsung's monoclonal antibody production relationship, was ever produced that I recall. Be really happy if I'm wrong, just a PR from ENZC. Getting the Clone3 and Clone7 patents would be huge, square them up with the AI stuff as a partner to be had by a BP. If that does not happen, ENZC is as big a scam as any basher ever said. If they do get it, apologies won't be needed, but a bit more humility would be in order.
In any case, Charles tried twice to devalue our shares, more and more, during the SAGA operation, and that should freak out anyone about what a risk he is.
GLTA
I can agree to most of that. The A&M lab is not like many other university labs looking for lease money. The PreClinical Sciences Center requires a peer review, which they did do on their mABS approach, it was for a while, partially published on the A&M website, and bragged about by the college. There was also an alleged, true there is no proof of it I can find, but a Clone3 Peer review by Samsung, in order to sign the manufacturing agreement.
Now I can't find a copy of the Samsung agreement, so who knows?
Alright, you make some good points, and I've respected them too, but at what point to you accept "ALL OF REALITY" and not just your overly-shaded part of it?
Joe had the company stuck in the mud for a long time, in came Harry and Charles, and things began to progress.
From 2018-2021, they had a lot of peer-reviewed research and testing, and many agreed, they have a decent bit of 'there" there.
Most research companies like this never generate a penny of revenue until they get to market, which is a very delayed milestone yes, but there has been some progress. You knew this when you invested in them, so what's your point there ??
Not all gripers here just failed to flip shares on the last couple of pps spikes, some have decent reason to go long still, and not risk what may not have been a lot of profit for them before on the spikes.
I see the potential, but still complain about the company incompetence, and now outright cowardice. CC is not the wonderful CEO some claimed, he's more amateur on the CEO side, maybe more clever on the money management side.
At this point, I believe the AI is real, and Clone 3/7 are both real. They did get some patents on that, some pending still. You can't even apply for a patent and keep it pending unless it has credible evidence to go along with it. Are you familiar with IP law at all? I've got two customer law firms who are tops in Houston with IP law, and they tell me the applications look good, and seem to have substance.
You also don't pay out a lab at the Texas A&M Preclinical Science's Center without something real and funded, because that's not cheap, it's too much for even a large scam and hoax.
So, while this may hit the sh!tter, there could be a pretty decent upturn.
With Patents Pending and decisions expected this late Spring and Summer, a spike at least could be in the works. Right now, I'm of the mind, if there is not serious, confirmable news by August, I'll be out of this one.
GLTA
The longer they take to put out another PR, the more desperate the situation really is. The only exception to this now, is a hail-mary funding party coming in to push things forward. I can just see the spin-doctors trying to create some stress-relieving fiction now.
GLTA
The longer they take to put out another PR, the more desperate the situation really is. The only exception to this now, is a hail-mary funding party coming in to push things forward. I can just see the spin-doctors trying to create some stress-relieving fiction now.
GLTA
Oh jeez....
If this is the craziest you've ever seen, you don't know the OTC:Pinks very well. This is still pretty moderate as far as crazy goes for such a Pink's stock loop.
MM's are indeed manipulating price-pps, that's proven over and over, even though it may be amateur MM price-play, it's still a significant factor of daily pps for this little organization.
Only fools ignore evidence before their very eyes.
Now you're right about the historical perspective, no arguing that, but no one came up with an Indian food scenario either. It's more likely Charles was setting up, or trying to, a golden chute sell-off that did not work, again or for the first time. Could be no pharma partners like him, or can address his terms, or he just sucks at bringing in funding parties and running negotiations. I too, keep getting a good laugh at how CC's been the "CEO we need."
In any case, if he does not figure it out fast, ENZC is cooked. Someone will be close to reverse engineering their stuff any day now. Regeneron was close over a year ago now. Lilly has an entirely new mABS development lab open now for the past 6 months. If his patents don't come in very soon, it's all moot anyway.
Cry-babies? All you did was bash. And now, to date, most of us have been in for 4+ years now, so go hold your breath bub....!
Exactly right, IMHO
Any biopharma in ENZC's current position could set up a group of 10 volunteers and take the Clone3 and Clone7 treatments, and report results 90-days later, by the current projections ENZC laid down for both over a year ago now. Take those results and patent plans to the funding candidates, and roll into formal trials, at least in Europe. This should have been underway a year back, but Charles was playing cute with share bluffing and probably some other hopes too.
Private trials are not at all so costly they couldn't have signed with a proper set of funding parties already. I think Charles had bigger plans to filter out the commons, and it did not go well for him. I've been on the same page with Dyno, DrHumi, SSPalmo and Maga+others, any DD led you in the same direction.
I just hope CC didn't burn up the critical time needed to beat the competition already.
I see .0136 by Monday morning. Have to decide whether to add more then and wait, or just wait for a spike overall.
Not quite 2B. I'm referring to a general SEC complaint anyone can file, not an outright lawsuit which would take a corporate lawyer with experience in shareholder protection would be required. Anyone can register a detailed complaint with the SEC, and for an OTC company, it takes a lot of them pointing to the same ticker to get them to begin looking at it in earnest.
Completely Agree.
All good points, but, was the deal consummated in final detail? My understanding was that all was signed off on and moving steadily in that direction, but if funding never came through, the entire agreement was voided and moot. Is that not correct? If I'm right, it's a good thing, because legally, ENZC owns everything back under its own original umbrella again.
I was pretty sure SAGA had to deliver, or everything reverted. I do half-suspect, Charles will try to keep the IP in the subsidiaries, even without the SAGA deal in place. If so, I'll send a formal complaint to the SEC myself about defrauding shareholders.
It's not fake tech or fake company MinerDiner. You may not know this, but to get the lab lease at Texas A&M, like most university research centers, you have to demonstrate a viable program with breakthrough potential, or they will simply lease the space to other, more viable, leasing candidates. I do know that ENZC got a breakneck rate, and had A&M published a potential notice of mABS research breakthroughs when ENZC first arrived there. In addition, patents granted (old) and the patents pending (recent) have to show property rights to the tech, (actual original research, documented authenticity of timeline possession etc...) or the patent applications get tossed out by the Patent offices (which they have not).
So, neither 'was fake', but they may be heading down a tight corridor of incompetent management at present. Hard to really tell. Either Charles has some big PR surprises coming up in the next 60-90 days, or he'll have screwed this all down a failure hole.
That he treats the rule of market entry like something to be cheaply manipulated, when he has better options, is purely imbecilic. IMHO
GLTA
Don't think you'll see much SAGA share movement Dr.
They're volume has been nearly nonexistent and limited. (Probably to keep the price up above $10.00 if the deal had gone through.) I don't think anyone but shareholding, preferred shares that is, principals at that, ever owned SAGA shares. I don't think much common stock was ever procured. The stock will stay the same because those that do own it don't know what to do for now.
It's a figurehead ticker now for the OTC.
Charles better have other funding lined up, don't know why, with the resources they do have to test some Clone 3&7 on some individual test cases, that they don't just publish some private data and ring-in the investors. That would be something to PR about.
Really good question. I'm betting they have a hedge in case it went south.
Yeah Doink, if Charles does not have other funding sources from private test results soon, the competition will complete their fly-by and make the company irrelevant.
-- Did they ever really intend any African Trials?
-- Did they ever get any results from said volunteer trials?
-- Is Chandra even still legally with ENZC other than being a preferred shareholder?
-- Is the lab at A&M even still open at the PreClinical Trial center? We'll know on 4/24/2024.
-- Are there any proven results even in a 1-person test result for Clone3 or Clone7 ??
-- Are half of the listed Board Members doing anything with ENZC now?
Some of the above may sound silly, until you begin to think about it and review all DD.
If I see a patent approval spike by late Summer or earlier, I'm probably selling it all.
As always, I'd be happy to be wrong, but I've seen a lot of these. ENZC had more ground underneath them than most OTC Biopharma's, but it's all crumbling now.
GLTA
Yeah Doink, if Charles does not have other funding sources from private test results soon, the competition will complete their fly-by and make the company irrelevant.
-- Did they ever really intend any African Trials?
-- Did they ever get any results from said volunteer trials?
-- Is Chandra even still legally with ENZC other than being a preferred shareholder?
-- Is the lab at A&M even still open at the PreClinical Trial center? We'll know on 4/24/2024.
-- Are there any proven results even in a 1-person test result for Clone3 or Clone7 ??
-- Are half of the listed Board Members doing anything with ENZC now?
Some of the above may sound silly, until you begin to think about it and review all DD.
If I see a patent approval spike by late Summer or earlier, I'm probably selling it all.
As always, I'd be happy to be wrong, but I've seen a lot of these. ENZC had more ground underneath them than most OTC Biopharma's, but it's all crumbling now.
GLTA
Yep, sure hope no one here bought shares of SAGA at $11.00 hoping to further capitalize on ENZC successes. It ain't gonna' happen.
But you watch, Charles will keep Koskinen in there somehow......
That makes more sense. I found a different owner's name listed as temporary in the local Baytown records. That Baytown address she's using, is probably a lease property she owns and pays less taxes on for declaring her primary business residence is still there in Baytown.
Nice catch, thanks Apollo. I sit corrected. And good too, maybe CC will be scared enough not to try and keep pushing his valued assets into a separately owned subsidiary again.
If that dummy of a CEO would publish some great private trial test results, I'd go do my part to market-up and solicit funding donors for ENZC myself. (And no naysayers our pumpers, it does not cost much to run and get complete analysis of privately run test trials either.)
SAGA's dead, let's march on. Wonder if they have the guts to put out a real PR now.....
That weak 10-Q filing might put off the delisting Apollo, it is in before the extended deadline. We'll see, but thanks, you're probably right.
Yeah, the house looks like a piece-of-sub-mediocrity, and that's being polite. The contact phone is out of New York, and the website registry of business for SAGA is the greater LA area in California. Case and company filings in Delaware.
If this is the lawyer, because it sure is not Koskinen, I wonder what sewers CC's buddies are operating out of? Not trying to dump on anyone living very modestly as my family did for decades, but this looks like a scammer's address.
Still, it's a 10-Q filing, maybe they just use a retired old guy as a filing clerk? I have no idea. Love to go outside his house, park for a while with a banner on my car that reads, "SAGALIAM: Scam or Business ??"
See if he comes out or calls the police behind shrouded windows to make me get lost. (Or her, Kelli, you say? Tax Person?)
LOL.... oh my, what we could do.....
Thanks Bonnie, we're very proud of here. She's a top researcher in animal protein/syntheses and genetic evolution from such studies and products to be involved. After a total of 12 years at Texas Tech U, getting her Master's and PhD completed, she's off to the next step in the process, higher-up research that will land her in a top genetics research lab in the next few years. That's her goal anyway. Gotta' be some commercial opportunities her old Dad can invest in down the road too.
What? When I first researched SAGALIAM, they had offices, allegedly, off a Freeway in California, just outside of LA, in a very nice building that I know well, used to drive by it for work for a large customer of ours, out there. It's a gorgeous business area.
They had the floor right under the top penthouse suite of offices, or so they said on their website. I'll go look at the 10-Q again, I was not looking for that. I do know, the addresses of legal filings commonly use the attorney's office address and not the company's address, so there may be that consideration. How funny they could be using an office or an attorney from Baytown, another area we know well. It would also explain why Sagaliam had to do the filing for an outside of state attorney, if he lives in Baytown, and the next hearing is in Delaware or California.
I would not panic about this one, the shell game of addresses in legal documents is typically all over the place.
GLTA
Me to Dr, me too.
On the tour, they encourage asking questions about how specific operations can be assisted or enhanced by being a lessee at Texas A&M. So that's how I know I can try, at least, to target questions about the ENZC lab, without seeming like I'm trying to pry into EZNC actual operations.
I'll be asking for a same-sized lab space, resources and what general activity can be expected at such a lab. "Like what are these guys doing as an example?"
I'll lead a basic set of malaise questions, in order to get an idea of activity in the ENZC lab.
Best I think I'll be able to do.
GLTA
Thanks for this SS, just finished reading it all, whew!
It reads very cleanly and appropriately, but it also does not impress anyone looking at SAGALIAM for any positive action. If they're not hiding potential investors waiting for patent approvals or test trial results, there's no way this company can do anything to fund formal trials into a market approval and release to the public in Europe or N. America.
Their balance sheets show a company clinging to existence and operations. I suspect SAGA ownership is either withholding private funds they plan to use, or they have investors ready to work through them, that they don't have to disclose, yet. If neither of the prior statements here are true, they're just smoke hoping something will drive outside capital investors to their door in time to keep it going. The latter statement would match the results of their last failed investment operation of 2021.
I keep wondering if CC and Koskinen grew up together gaming the systems over in Bulgaria. Consistent operational losses with half a mil in the bank, sure isn't funding a $450 million project any time soon. Hope they have Angel Investors ready that they're keeping quiet. No other path to success here that I can read from the 10-Q.
Probably so Bonnie, but if the lab is gone, I'd be a lot more worried. Really strange that none of the public service phone lines regarding the Preclinical Trials Center at Texas A&M ever answer and never return a voicemail, the way their auto-attendant says they will. What the heck with prestigious Texas A&M?? I made sure we called the right phone numbers too, all posted right there on their website. Odd to say the least.
If the lab is buzzing and busy, or at least notably occupied with workers, I'll feel a lot better about ENZC. In any case, I'll get a picture or two for posting here. If my daughter hadn't gotten the research job at Texas A&M CC-Kingsville, I'd never be getting back in there at all.
GLTY
You've got all of that right SS. I was just referring to the common possibility here that in the wait time to the next hearing, both sides' attorneys typically speak and try to reach a settlement before the next judicial step is taken. There would be no PR's on it, since its informal and just an exploratory method of avoiding more legal costs on both sides.
Doubtful that happened at this date, but it may have.
GLTY